Rybrevant (amivantamab-vmjw) - J&J
petosemtamab (MCLA-158) - Genmab
ficerafusp alfa (BCA101) - Bicara Therapeutics
Idafang (ivonescimab) - Summit Therapeutics
https://storage.unitedwebnetwork.com/files/991/abstract/2026/EACR26-0684.htm
 
I. Rolli 1; M. Lucchetta 1; S. Cavalieri 2,3; S. Alfieri 2; D. Lenoci 1; N. Farina 1; M. Ficorilli 1; L. Licitra 2,3; L. De Cecco 1
 
Jun 17, 2026
 
Prev Next